Scott G Weiner MD
Associate Professor, Emergency Medicine, Tufts Medical Center
Join to View Full Profile
750 Washington StDept of Emergency Medicine Tuftsnemc 311Boston, MA 02111
Phone+1 617-636-4720
Fax+1 617-264-6848
Dr. Weiner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Emergency Medicine, 2000 - 2003
University of California, Irvine, School of MedicineClass of 2000
Certifications & Licensure
MA State Medical License 2002 - 2026
American Board of Emergency Medicine Emergency Medicine
American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- Individual and prescription level factors associated with overdose in opioid naïve older people.Kacey Little, Sanae El Ibrahimi, Jiah Yoo, Diana Flores, Michelle Hendricks
Journal of the American Geriatrics Society. 2025-04-01 - Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials.Todd Bertoch, Dominick D'Aunno, Jessica McCoun, Daneshvari Solanki, Louise Taber
Anesthesiology. 2025-03-21 - Mapping Emergency Medicine Data to the Observational Medical Outcomes Partnership Common Data Model: A Gap Analysis of the American College of Emergency Physicians Cli...Inessa Cohen, Zihan Diao, Pawan Goyal, Aarti Gupta, Kathryn Hawk
Journal of the American College of Emergency Physicians Open. 2025-02-01
Press Mentions
The Deadly Diabetes Risk You Don’t Know AboutOctober 10th, 2024- When It Comes to Post-Surgical Opioid Tapering, You’re on Your Own!August 20th, 2024
- Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute PainJuly 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
